262 related articles for article (PubMed ID: 21127203)
1. Transforming growth factor-beta signaling pathway in patients with Kawasaki disease.
Shimizu C; Jain S; Davila S; Hibberd ML; Lin KO; Molkara D; Frazer JR; Sun S; Baker AL; Newburger JW; Rowley AH; Shulman ST; Burgner D; Breunis WB; Kuijpers TW; Wright VJ; Levin M; Eleftherohorinou H; Coin L; Popper SJ; Relman DA; Fury W; Lin C; Mellis S; Tremoulet AH; Burns JC
Circ Cardiovasc Genet; 2011 Feb; 4(1):16-25. PubMed ID: 21127203
[TBL] [Abstract][Full Text] [Related]
2. Genetic variants of ADAM17 are implicated in the pathological process of Kawasaki disease and secondary coronary artery lesions via the TGF-β/SMAD3 signaling pathway.
Peng Q; Deng Y; Yang X; Leng X; Yang Y; Liu H
Eur J Pediatr; 2016 May; 175(5):705-13. PubMed ID: 26833052
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of transforming growth factor-β signaling pathway and Kawasaki disease in the Taiwanese population.
Kuo HC; Onouchi Y; Hsu YW; Chen WC; Huang JD; Huang YH; Yang YL; Chao MC; Yu HR; Juan YS; Kuo CM; Yang KD; Huang JS; Chang WC
J Hum Genet; 2011 Dec; 56(12):840-5. PubMed ID: 22011813
[TBL] [Abstract][Full Text] [Related]
4. Role of TGF-β Signaling in Remodeling of Noncoronary Artery Aneurysms in Kawasaki Disease.
Lee AM; Shimizu C; Oharaseki T; Takahashi K; Daniels LB; Kahn A; Adamson R; Dembitsky W; Gordon JB; Burns JC
Pediatr Dev Pathol; 2015; 18(4):310-7. PubMed ID: 25856633
[TBL] [Abstract][Full Text] [Related]
5. HMGB1 gene polymorphism is associated with coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.
Ahn JG; Bae Y; Shin D; Nam J; Kim KY; Kim DS
Rheumatology (Oxford); 2019 May; 58(5):770-775. PubMed ID: 30535242
[TBL] [Abstract][Full Text] [Related]
6. TGF-β (Transforming Growth Factor-β) Signaling Protects the Thoracic and Abdominal Aorta From Angiotensin II-Induced Pathology by Distinct Mechanisms.
Angelov SN; Hu JH; Wei H; Airhart N; Shi M; Dichek DA
Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2102-2113. PubMed ID: 28729364
[TBL] [Abstract][Full Text] [Related]
7. Transcript abundance patterns in Kawasaki disease patients with intravenous immunoglobulin resistance.
Fury W; Tremoulet AH; Watson VE; Best BM; Shimizu C; Hamilton J; Kanegaye JT; Wei Y; Kao C; Mellis S; Lin C; Burns JC
Hum Immunol; 2010 Sep; 71(9):865-73. PubMed ID: 20600450
[TBL] [Abstract][Full Text] [Related]
8. Amphotericin B-copper (II) complex alters transcriptional activity of genes encoding transforming growth factor-beta family members and related proteins in renal cells.
Gola J; Strzałka-Mrozik B; Wieczorek E; Kruszniewska-Rajs C; Adamska J; Gagoś M; Czernel G; Mazurek U
Pharmacol Rep; 2017 Dec; 69(6):1308-1314. PubMed ID: 29128814
[TBL] [Abstract][Full Text] [Related]
9. [Association of single nucleotide polymorphism in TGFBR2 gene with Kawasaki disease and coronary artery lesions].
Shi CP; Zhang HY
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Sep; 15(9):767-70. PubMed ID: 24034922
[TBL] [Abstract][Full Text] [Related]
10. Sequencing of TGF-beta pathway genes in familial cases of intracranial aneurysm.
Santiago-Sim T; Mathew-Joseph S; Pannu H; Milewicz DM; Seidman CE; Seidman JG; Kim DH
Stroke; 2009 May; 40(5):1604-11. PubMed ID: 19299629
[TBL] [Abstract][Full Text] [Related]
11. Genome-Wide Association Study Identifies Novel Susceptibility Genes Associated with Coronary Artery Aneurysm Formation in Kawasaki Disease.
Kuo HC; Li SC; Guo MM; Huang YH; Yu HR; Huang FC; Jiao F; Kuo HC; Andrade J; Chan WC
PLoS One; 2016; 11(5):e0154943. PubMed ID: 27171184
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-β (TGF-β) signaling in healthy human fetal skin: a descriptive study.
Walraven M; Beelen RH; Ulrich MM
J Dermatol Sci; 2015 May; 78(2):117-24. PubMed ID: 25795202
[TBL] [Abstract][Full Text] [Related]
13. Immunogenetics of Kawasaki disease.
Kumrah R; Vignesh P; Rawat A; Singh S
Clin Rev Allergy Immunol; 2020 Aug; 59(1):122-139. PubMed ID: 32200494
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in the potential functional regions of the TGF-β 1 and TGF-β receptor genes and disease susceptibility in HBV-related hepatocellular carcinoma patients.
Xin Z; Zhang W; Xu A; Zhang L; Yan T; Li Z; Wu X; Zhu X; Ma J; Li K; Li H; Liu Y
Mol Carcinog; 2012 Oct; 51 Suppl 1():E123-31. PubMed ID: 22290546
[TBL] [Abstract][Full Text] [Related]
15. Genetic variants of CD209 associated with Kawasaki disease susceptibility.
Kuo HC; Huang YH; Chien SC; Yu HR; Hsieh KS; Hsu YW; Chang WC
PLoS One; 2014; 9(8):e105236. PubMed ID: 25148534
[TBL] [Abstract][Full Text] [Related]
16. Human pulmonary acinar aplasia: reduction of transforming growth factor-beta ligands and receptors.
Chen MF; Gray KD; Prentice MA; Mariano JM; Jakowlew SB
Pediatr Res; 1999 Jul; 46(1):61-70. PubMed ID: 10400136
[TBL] [Abstract][Full Text] [Related]
17. Effects of Chinese traditional compound, JinSanE, on expression of TGF-beta1 and TGF-beta1 type II receptor mRNA, Smad3 and Smad7 on experimental hepatic fibrosis in vivo.
Song SL; Gong ZJ; Zhang QR; Huang TX
World J Gastroenterol; 2005 Apr; 11(15):2269-76. PubMed ID: 15818738
[TBL] [Abstract][Full Text] [Related]
18. The role of TGF-β and myofibroblasts in the arteritis of Kawasaki disease.
Shimizu C; Oharaseki T; Takahashi K; Kottek A; Franco A; Burns JC
Hum Pathol; 2013 Feb; 44(2):189-98. PubMed ID: 22955109
[TBL] [Abstract][Full Text] [Related]
19. TGFβRIIb mutations trigger aortic aneurysm pathogenesis by altering transforming growth factor β2 signal transduction.
Bee KJ; Wilkes DC; Devereux RB; Basson CT; Hatcher CJ
Circ Cardiovasc Genet; 2012 Dec; 5(6):621-9. PubMed ID: 23099432
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of TGFβ-1 and TGFBR2 in relation to coronary artery disease in a Chinese population.
Yang M; Zhu M; Tang L; Zhu H; Lu Y; Xu B; Jiang J; Chen X
Clin Biochem; 2016 Aug; 49(12):873-8. PubMed ID: 27234600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
